Stay updated on Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.

Latest updates to the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check34 days agoChange DetectedThe date '2025-02-12' has been added, while '2024-04-26' has been removed from the page.SummaryDifference0.9%
- Check41 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check48 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check62 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference1.0%
Stay in the know with updates to Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.